Newsletter Archive
-
08.29.23 -- The Global Landscape For Synthetic Biology In Biopharma Through 2035
8/29/2023
08/29/23 Drug Discovery Online Newsletter
-
08.22.23 -- Targeting Von Willebrand Factor With An RNA Aptamer To Treat Stroke
8/22/2023
08/22/23
-
08.21.23 -- Can Advances In Nanoparticle Engineering Technology Improve New Drug Candidate Success Rates?
8/21/2023
08/21/23 Drug Discovery Online Newsletter
-
08.15.23 -- Should My Biotech Startup Buy Or Produce The Proteins We Use?
8/15/2023
08/15/23 Drug Discovery Online Newsletter
-
08.10.23 -- Biomanufacturing Process Optimization And Scaling
8/10/2023
08/10/23 Drug Discovery Online Newsletter
-
08.08.23 -- Improve Efficiency And Consistency In Drug Release With Nanoforming
8/8/2023
08/08/23 Drug Discovery Online Newsletter
-
08.08.23 -- The 2 Factors Driving A Surge In Aptamer Use In Drug Discovery
8/8/2023
08/08/23 Drug Discovery Online Newsletter
-
08.01.23 -- How Predictive Can Regulatory Drug Abuse Potential Investigations Be in Animals?
8/1/2023
08/01/23
-
07.27.23 -- A Patient- And Planet-Centric Approach To Enhancing Medicines In Development
7/27/2023
07/27/23 Drug Discovery Online Newsletter
-
07.25.23 -- FDA Seeks Input On AI Adoption In Drug Development And Manufacture
7/25/2023
07/25/23 Drug Discovery Online Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more